This paper provides a comprehensive overview of stability-related aspects of quantitative bioanalysis and recommends science-based best practices, covering small and large molecules as well as chromatographic and ligand-binding assays. It addresses general aspects, such as the use of reference values, transferability and treatment of failing stability results, and also focuses on specific types of stability assessment: bench-top, freeze/thaw and long-term frozen stability, stock stability, extract stability, stability in whole blood, tissue and urine, and stability of endogenous analytes, in special matrix types and in incurred samples.
GBC regulated bioanalysis stability assessment
This is a preview of subscription content, log in to check access.
The authors want to express their gratitude to Marian Kelley, Lauren Stevenson, and Binodh DeSilva for their valuable discussions during the preparation of the manuscript.
Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet. 1991;16:249–55.PubMedCrossRefGoogle Scholar
Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res. 2000;17:1551–7.PubMedCrossRefGoogle Scholar
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine (2001) Guidance for industry: bioanalytical method validationGoogle Scholar
European Medicines Agency, Committee for Medicinal Products for Human Use (2011) Guideline on bioanalytical method validationGoogle Scholar
Agência Nacional de Vigilância Sanitária, Brazil. Resolução – RDC No 27. May 2012.Google Scholar
Ministry of Health, Labour and Welfare, Japan (2013) Guideline on bioanalytical method validation in pharmaceutical developmentGoogle Scholar
DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20:1885–900.PubMedCrossRefGoogle Scholar
Viswanathan CT, Bansal S, Booth B, et al. Workshop/conference report—quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 2007;9:E30–42.PubMedCentralCrossRefGoogle Scholar
Nowatzke W, Woolf E. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS J. 2007;9:E117–22.PubMedCentralPubMedCrossRefGoogle Scholar
Lowes S, Jersey J, Shoup R, et al. Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for bioanalysis. Bioanalysis. 2011;3:1323–32.PubMedCrossRefGoogle Scholar
Freisleben A, Brudny-Klöppel M, Mulder H, et al. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis. Bioanalysis. 2011;3:1333–6.PubMedCrossRefGoogle Scholar
Lowes S, Boterman M, Doig M, et al. Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for bioanalysis (GCC). Bioanalysis. 2012;4:2117–26.PubMedCrossRefGoogle Scholar
Van Amsterdam P, Companjen A, Brudny-Kloeppel M, et al. The European Bioanalysis Forum community’s evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. Bioanalysis. 2013;5:645–59.PubMedCrossRefGoogle Scholar
Sennbro CJ, Knutsson M, Timmerman P, et al. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required? Bioanalysis. 2011;3:2389–91.PubMedCrossRefGoogle Scholar
Timm U, Wall M, Dell D. A new approach for dealing with the stability of drugs in biological fluids. J Pharm Sci. 1985;74:972–7.PubMedCrossRefGoogle Scholar
Houghton R, Horro Pita C, Ward I, Macarthur R. Generic approach to validation of small-molecule LC-MS/MS biomarker assays. Bioanalysis. 2009;1:1365–74.PubMedCrossRefGoogle Scholar